Περιγραφή
This concise, yet authoritative, clinical reference guide fulfils the needs of diverse clinicians, pharmacists and allied health professionals prescribing for Parkinson’s disease and movement disorders in contemporary clinical practice. With chapters on newly approved drugs and their effects on motor and non-motor symptoms, information is also given on their use in particular populations including the elderly and patients with cognitive impairment. Each chapter includes pharmacological/biochemical rationale for drug use, a general guide to therapeutic use, pharmacokinetics, interaction profile, adverse effects, dosing and use, special population considerations, costs and value for money considerations, clinical vignette, a summary overview, and suggested reading. Ordered alphabetically and perfect for quick reference use, the guide is practical and essential for all prescribers with responsibility for patients with Parkinson’s disease, including neurologists, geriatricians, internists, neurosurgeons, psychiatrists, family physicians, pharmacists as well as allied health professionals and resident, fellow, and student trainees in all related medical fields.
- This concise, yet authoritative prescriber’s guide features coverage of newly approved drugs such as safinamide and opicapone, clearly detailing drug applications, indications, adverse effects, and pharmacokinetic interactions
- Designed to provide broad yet concise and authoritative information, this guide is able to support the diversity of Parkinson’s disease and movement disorders prescribers in contemporary clinical practice from neurologists to geriatricians
- In full colour, the book covers 55 Parkinson’s disease drugs in alphabetic order, with colour coded information within each section, to support quick reference use and effective guidance
- The book contains information on the cost of each drug, based on UK data
- Clinical vignettes are included, giving practical tools to promote optimal prescribing
